Compare CRDL & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDL | ACU |
|---|---|---|
| Founded | 2017 | 1867 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.3M | 154.0M |
| IPO Year | N/A | N/A |
| Metric | CRDL | ACU |
|---|---|---|
| Price | $0.97 | $40.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 633.4K | 8.1K |
| Earning Date | 11-13-2025 | 10-21-2025 |
| Dividend Yield | N/A | ★ 1.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.45 |
| Revenue | N/A | ★ $194,960,991.00 |
| Revenue This Year | N/A | $2.19 |
| Revenue Next Year | N/A | $4.55 |
| P/E Ratio | ★ N/A | $16.56 |
| Revenue Growth | N/A | ★ 2.35 |
| 52 Week Low | $0.77 | $34.35 |
| 52 Week High | $1.59 | $45.25 |
| Indicator | CRDL | ACU |
|---|---|---|
| Relative Strength Index (RSI) | 41.25 | 57.27 |
| Support Level | $0.88 | $35.61 |
| Resistance Level | $1.03 | $41.74 |
| Average True Range (ATR) | 0.04 | 1.37 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 6.66 | 68.58 |
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.